1-8 of 8
Huiqing Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene Therapy Expressing Platelet-Derived Factor VIII for Correction of Hemophilia Α with a History of Inhibitors

David A. Wilcox, Myriam Armant, Lynn Malec, Qizhen Shi, Bryon D. Johnson, Huiqing Xu, Lily M. Du, Lisa J. Duffy, Frederic D. Bushman, James H. Jerkins, Peiman Hematti, Ruta Brazauskas, Shawn M. Jobe, Parameswaran N. Hari, Mary Eapen
Journal: Blood
Blood (2023) 142 (Supplement 1): 2249.
https://doi.org/10.1182/blood-2023-172845
Published: 2023
Journal Articles

Single Cell Cytokine Analyses of Bispecific, Tandem, Anti-CD20, Anti-CD19 CAR T-Cells from Patients with Relapsed, Refractory B-Cell Malignancies

Fateeha Furqan, Huiqing Xu, Joanna Zurko, Timothy S. Fenske, Bryon Johnson, Mehdi Hamadani, Nirav N. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12690–12691.
https://doi.org/10.1182/blood-2022-169198
Published: 2022
Journal Articles

Bispecific LV20.19 CAR T-Cells Expanded in IL-7 and IL-15 Have Greater Polyfunctionality and Polyfunctional Strength Than CAR T-Cells Expanded in IL-2

Joanna C. Zurko, Huiqing Xu, Katherine Chaney, Timothy S. Fenske, Mehdi Hamadani, Dina Schneider, Parameswaran Hari, Bryon Johnson, Nirav N. Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 1728.
https://doi.org/10.1182/blood-2021-146882
Published: 2021
Journal Articles

Manufacturing Bispecific LV20.19 CAR T-Cells with IL-7 & IL-15 for a Shorter Duration Improves CAR T-Cell Immunophenotype While Maintaining Target Cell Dose

Joanna C. Zurko, Katherine Chaney, Huiqing Xu, Dina Schneider, Parameswaran Hari, Bryon Johnson, Nirav N. Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 3883.
https://doi.org/10.1182/blood-2021-147405
Published: 2021
Journal Articles

Single-Cell Cytokine Analysis of LV20.19 Bispecific CAR T-Cell Products from a Phase I Clinical Trial

Huiqing Xu, MD, Katherine Chaney, MS, Bryon Johnson, PhD, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Boro Dropulic, PhDMBA, Dina Schneider, PhD, Parameswaran Hari, MD MRCP, Nirav N. Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-136805
Published: 2020
Journal Articles

Point-of-Care Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells in a Standard Academic Cell Processing Facility for a Phase I Clinical Trial in Relapsed, Refractory NHL

Fenlu Zhu, PhD, Nirav N Shah, MD, Dina Schneider, PhD, Huiqing Xu, MD, Katherine Chaney, MS, Lawrence Luib, MS, Carolyn A. Keever-Taylor, DPhil, Boro Dropulic, PhD, Rimas Orentas, PhD, Parameswaran Hari, MBBS, MD, Bryon Johnson, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4553.
https://doi.org/10.1182/blood-2018-99-116566
Published: 2018
Journal Articles

CAR-T Cell Production Using the Clinimacs ® Prodigy System

Fenlu Zhu, PhD, Nirav N. Shah, MD MSHP, Huiqing Xu, MD, Dina Schneider, Rimas Orentas, PhD, Boro Dropulic, Parameswaran Hari, MD MRCP, MS, Carolyn A. Keever-Taylor, PhD
Journal: Blood
Blood (2016) 128 (22): 5724.
https://doi.org/10.1182/blood.V128.22.5724.5724
Published: 2016
Journal Articles

Allo-Reactive Potential of Multi-Virus Specific Cytotoxic T Cell Lines Recognizing Adenovirus Hexon, Cytomegalovirus pp65 and Epstein Barr Virus.

Xin Yao, MD, Fenlu Zhu, Ph, D, Huiqing Xu, MD, Carolyn A. Keever-Taylor, PhD
Journal: Blood
Blood (2009) 114 (22): 5121.
https://doi.org/10.1182/blood.V114.22.5121.5121
Published: 2009